FDA Inspection 936556 — Hybio Pharmaceutical Co. Ltd (Site 1)
The FDA completed an inspection of Hybio Pharmaceutical Co. Ltd (Site 1) on Jun 26, 2015 in Shenzhen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 26, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shenzhen (China)